Classic textbooks teach that the incidence of keratoconus is one per 2,000. That would equate to about 170,000 patients with keratoconus in the United States.However, more recent studies suggest ...

Keratoconus is a disorder of the eye characterized by progressive thinning and protrusion of ... This Primer outlines the epidemiology and pathophysiology of POI, including associated gene ...

Without a definitive keratoconus diagnosis, billing and coding for such testing is typically not possible. Without a reimbursable code for screening or suspicion, adoption of the necessary devices ...

INDIANAPOLIS (WISH)– “Do you know what keratoconus is?” an ophthalmologist asked me while closely analyzing my eyes through one of those uncomfortable machines they use at the eye doctor’s ...

If left untreated, keratoconus can lead to loss of vision and even blindness and is one of the leading causes of corneal transplant (penetrating keratoplasty) in the United States.

Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its non-invasive treatment potential.

Glaukos (GKOS) announced the submission of its New Drug Application NDA to the U.S. Food and Drug Administration FDA or Epioxa or Epi-on, its next-generation corneal cross-linking iLink therapy ...